The revised Intimation is attached.

Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com September 9, 2026 FHL/SEC/2026-27 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code:532843 Sub: Revised Intimation for schedule of Investors / Analysts’ meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Madam/Sir, Please find the revised intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of upcoming Investor Meetings with the Management of IHH Healthcare Berhad (“IHH”) and Fortis Healthcare Limited (“FHL”), to discuss about the general business update and the industry, in which the Company operates (This Intimation is in reference to the intimation filed earlier today). The schedule of the Investors / Analysts’ meet is as below: Sr. Date & Time Investors / Analysts / Mode of Type of Location No Events Meeting Meeting 1 Date: 14th Non-Deal Road show London September 2026 and (Organized by Jefferies) In-person Group Meet 15th September 2026 Time: 8 AM to 5 PM BST/12.30 PM to 9.30 PM IST Please note that the above schedule and timings are subject to changes due to exigencies on the part of the Investors/Company. No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investor meet. This is for your kind information and records. Thanking you, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer ICSI Membership: A14783 FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933